Abstract
The aim of the paper is to give an overview of the epidemiology, treatment pattern and quality, as well as policy issues and disease burden of colorectal cancer (CRC) in Hungary. Colorectal cancer is the second most common cause of cancer-related death in both males and females in Hungary. The Hungarian Cancer Registry collects data on the epidemiological characteristics of CRC. Two pilot programmes (1997/1998 and 2003/2004) were conducted for population-based screening of CRC using both immunological and guaiac faecal occult blood testing (FOBT). The National Health Insurance Fund Administration (NHIFA) spends altogether € 38.9 million a year on the treatment of CRC. It is hoped that the introduction of an accepted and cost-effective screening programme for CRC can reduce the high CRC burden in Hungary.
Similar content being viewed by others
References
Boncz, I., Nagy, J., Sebestyen, A., Korosi, L.: Financing of health care services in Hungary. Eur. J. Health Econ. 5, 252–258 (2004)
Gulácsi, L., David, T., Dózsa, C.S.: Pricing and reimbursement of drugs and medical devices in Hungary. Eur. J. Health Econ. 3, 271–278 (2002)
Boncz, I., Sebestyen, A.: Financial deficits in the health services of the UK and Hungary. Lancet 368, 917–918 (2006)
Dobrossy, L.: Cancer mortality in central-eastern Europe: facts behind the fi gures. Lancet Oncol. 3, 374–381 (2002)
Boncz, I., Sebestyen, A., David, T.: Comparative analysis of drug cost of breast, cervical and colorectal cancer in Hungary. Value Health 8, A42 (2005)
Ottó, S., Kásler, M.: Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programs. Magy. Onkol. 49, 99–101 and 103–107 (2005)
Hungarian National Cancer Registry (2001)
Tusnády, G., Gaudi, I., Rejto, L., Kásler, M., Szentirmay, Z.: Survival chances of Hungarian cancer patients in the national cancer registry. Magy. Onkol. 52, 339–349 (2008)
Jensen, O.M., Parkin, D.M., MacLennan, R., Muir, C.S., Skeet, R.G.: Cancer Registration: Principles and Methods. IARC Scientific Publications No. 95, Lyon, France (1991)
Kovács, L., Pataki, M.: New Hungarian National Cancer Registry. ERCIM NEWS. January, 58 (2007)
Tusnády, G., Gaudi, I., Rejto, L., Kásler, M., Szentirmay, Z.: Survival chances of Hungarian cancer patients in the national cancer registry (Translated from Hungarian: a magyar daganatos betegek túlélési esélye a Nemzeti Rákregiszter adatai alapján). Magy. Onkol. 52, 339–349 (2008)
Ottó, S.Z., Kasler, M.: Cancer mortality and incidence in Hungary in relation to international data. Magy. Onkol. 46, 111–117 (2002)
Ministry of Health: Hungarian National Cancer Control Programme. Budapest (2006)
Ottó, S., Németh, M.: Double immunochemical screening test (hemoglobin and albumin) for the detection of occult intestinal bleeding. J. Clin. Lab. Anal. 7, 301–306 (1993)
Boncz, I., Sebestyén, A., Dózsa, C., et al.: Health economics analysis of colorectal screening. (Translated from Hungarian: a colorectalis szűrések egészség-gazdaságtani elemzése). Magy. Onkol. 48, 111–115 (2004)
Csonka, C., Molnár, C., Németh, M., Ottó, S.: Results of and experinces with colorectal screening in town Ajka (Translated from Hungarian: Az ajkai vastagbélszűrés eredményei és tapasztalatai). Magy. Onkol. 48, 29 (2004)
Boncz, I., Sebestyen, A., Pinter, I., Betlehem, J., Kriszbacher, I., Csere, T., Mangel, L., Bodis, J.: Age-group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J. Clin. Oncol. 25, 4501–4502 (2007)
Ottó, S., Döbrőssy, L.: Screening for colorectal cancer with immunological FOBT. Br. J. Cancer 90, 1871–1872 (2004)
Döbrősy, L., Kovács, A., Budai, A., Cornides, A., Ottó, S., Tulassay, Z.: The state of the colorectal screening in Hungary: lessons of the pilot programs. Orv. Hetil. 148, 1787–1793 (2007)
Boncz, I., Sebestyen, A., Dobrossy, L., Pentek, Z., Budai, A., Kovacs, A., Dozsa, C., Ember, I.: The organization and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. Ann. Oncol. 18, 795–799 (2007)
Boncz, I.: Organized nationwide breast cancer screening programme was introduced in Hungary in 2002. Swiss. Med. Wkly. 136, 328 (2006)
Boncz, I., Sebestyen, A., Pinter, I., Battyany, I., Ember, I.: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J. Med. Screen 15, 14–17 (2008)
Boncz, I.: Prevention of cervical cancer screening in low-resource settings. JAMA 295, 1248 (2006)
Kovács, A., Döbrőssy, L., Budai, A., Boncz, I., Cornides, Á.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29, 5–9 (2008)
Boncz, I., Sebestyen, A., Ember, I.: Organized, nationwide cervical cancer screening programme in Hungary. Gynecol. Oncol. 106, 272–273 (2007)
Barry, M.J.: Screening for prostate cancer—the controversy that refuses to die. N. Engl. J. Med. 360, 1351–1354 (2009)
Schröder, F.H., Hugosson, J., Roobol, M.J., ERSPC Investigators, et al.: Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320–1328 (2009)
Andriole, G.L., Grubb 3rd, R.L., Buys SS, P.L.C.O., Team, Project., et al.: Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310–1319 (2009)
Boncz, I., Sebestyen, A., Betlehem, J., et al.: The effect of the performance volume limit (PVL) on the DRG financing of the Hungarian hospitals. Value Health 11, A48 (2008)
Decree of the Ministry of Health, Social and Family Affairs on the principles of inclusion of registered medicinal and special nutritional products into the reimbursement system and on the modification of the inclusion or reimbursement status. 32/2004. (IV.26.) (2004)
Act XCVIII of 2006 on safety and efficient supply of pharmaceuticals and medical devices as well as on the general rules of pharmaceuticals distribution. Official Gazette No. 146; 29 November 2006
Act XCVIII of 2006 on safety and efficient supply of pharmaceuticals and medical devices as well as on the general rules of pharmaceuticals distribution. Official Journal No. 146; 29 November 2006
Wilking, N., Jönsson, B.: A Pan-European Comparison Regarding Patient Access to Cancer Drugs. Karolinska Institutet in collaboration with Stockholm School of Economics Stockholm, Sweden (2005)
Hungarian College of Surgeons on behalf of the Ministry of Health: Professional protocoll of colorectal and anal cancer. (Translated from Hungarian: Az Egészségügyi Minisztérium szakmai protokollja Vastagbél- és végbélrák Készítette: A Sebészeti Szakmai kollégium). Budapest (2006)
Harisi, R., Bodoky, G., Borsodi, M., Flautner, L., Weltner, J.: Rectal cancer therapy: decision making on basis of quality of life? Zentralbl. Chir. 129, 139–148 (2004)
Hungarian Ministry of Health. List of professional guidelines. http://www.eum.hu/egeszsegpolitika/minosegfejlesztes/szakmairanyelvek. Accessed August 2009
Acknowledgment
We wish to express our gratitude to Prof. György Bodoky, MD, PhD, President, Hungarian Society of Clinical Oncology, Teaching Hospital St. László, Department of Oncology, Budapest, for his valuable discussion and comments during filling in the questionnaire.
Conflict of interest statement
The authors do not report any conflict of interest associated with this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boncz, I., Brodszky, V., Péntek, M. et al. The disease burden of colorectal cancer in Hungary. Eur J Health Econ 10 (Suppl 1), 35–40 (2010). https://doi.org/10.1007/s10198-009-0192-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-009-0192-z